755 related articles for article (PubMed ID: 16247563)
41. Demographic and clinical correlates of substance use disorders in first episode psychosis.
Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
[TBL] [Abstract][Full Text] [Related]
42. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
43. Personality characterizations of outpatients with schizophrenia, schizophrenia with substance abuse, and primary substance abuse.
Reno RM
J Nerv Ment Dis; 2004 Oct; 192(10):672-81. PubMed ID: 15457110
[TBL] [Abstract][Full Text] [Related]
44. Rural and urban differences in patients with a dual diagnosis.
Mueser KT; Essock SM; Drake RE; Wolfe RS; Frisman L
Schizophr Res; 2001 Mar; 48(1):93-107. PubMed ID: 11278157
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with receipt of behavioral health services among persons with substance dependence.
Green-Hennessy S
Psychiatr Serv; 2002 Dec; 53(12):1592-8. PubMed ID: 12461221
[TBL] [Abstract][Full Text] [Related]
46. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
[TBL] [Abstract][Full Text] [Related]
47. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
Timko C; Dixon K; Moos RH
Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
[TBL] [Abstract][Full Text] [Related]
48. State psychiatric hospital patients with past arrests for violent crimes.
Grossman LS; Haywood TW; Cavanaugh JL; Davis JM; Lewis DA
Psychiatr Serv; 1995 Aug; 46(8):790-5. PubMed ID: 7583479
[TBL] [Abstract][Full Text] [Related]
49. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
50. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
51. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
[TBL] [Abstract][Full Text] [Related]
52. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
[TBL] [Abstract][Full Text] [Related]
53. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
[TBL] [Abstract][Full Text] [Related]
54. Sex differences in first-admission psychiatric inpatients with and without a comorbid substance use disorder.
Gramaglia C; Bert F; Lombardi A; Feggi A; Porro M; Siliquini R; Gualano MR; Torre E; Zeppegno P
J Addict Med; 2014; 8(5):351-8. PubMed ID: 25054860
[TBL] [Abstract][Full Text] [Related]
55. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice.
Wilk J; West JC; Rae DS; Regier DA
Am J Addict; 2006; 15(2):180-5. PubMed ID: 16595357
[TBL] [Abstract][Full Text] [Related]
56. Problems in the recognition and treatment of patients with dual diagnoses.
Milling RN; Faulkner LR; Craig JM
J Subst Abuse Treat; 1994; 11(3):267-71. PubMed ID: 8072056
[TBL] [Abstract][Full Text] [Related]
57. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
58. Psychiatric care of patients with depression and comorbid substance use disorders.
Montoya ID; Svikis D; Marcus SC; Suarez A; Tanielian T; Pincus HA
J Clin Psychiatry; 2000 Sep; 61(9):698-705; quiz 706. PubMed ID: 11030495
[TBL] [Abstract][Full Text] [Related]
59. Mental health multimorbidity and poor quality of life in patients with schizophrenia.
Bhalla IP; Stefanovics EA; Rosenheck RA
Schizophr Res; 2018 Nov; 201():39-45. PubMed ID: 29709490
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of alcohol and drug abuse in schizophrenic inpatients.
Soyka M; Albus M; Kathmann N; Finelli A; Hofstetter S; Holzbach R; Immler B; Sand P
Eur Arch Psychiatry Clin Neurosci; 1993; 242(6):362-72. PubMed ID: 8323987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
